0001731038-19-000002.txt : 20190122 0001731038-19-000002.hdr.sgml : 20190122 20190122101605 ACCESSION NUMBER: 0001731038-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190122 DATE AS OF CHANGE: 20190122 EFFECTIVENESS DATE: 20190122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lindy Biosciences, Inc. CENTRAL INDEX KEY: 0001731038 IRS NUMBER: 815178025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-330999 FILM NUMBER: 19534563 BUSINESS ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-748-4480 MAIL ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Lindy Biosciences, LLC DATE OF NAME CHANGE: 20180212 D 1 primary_doc.xml X0708 D LIVE 0001731038 Lindy Biosciences, Inc. 400 Park Offices Drive Suite 201 Research Triangle Park NC NORTH CAROLINA 27709 919-748-4480 DELAWARE Lindy Biosciences, LLC Corporation true 2016 Deborah Bitterfield 400 Park Offices Dr. Suite 201 Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Promoter Karen LeVert 400 Park Offices Dr. Suite 201 Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Sreekar Gadde 400 Park Offices Dr. Suite 201 Research Triangle Park NC NORTH CAROLINA 27709 Director Biotechnology Decline to Disclose 06b false 2019-01-11 false true false 0 1602734 547736 1054998 false 6 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false Lindy Biosciences, Inc. Deborah Bitterfield Deborah Bitterfield CEO 2019-01-21